中文|English
Sign Up
Shopping cart
Search

The CDE issued a notice to solicit public opinion on the 《Clinical technical requirements for unlisted drugs in China 》

Column：Industry News Time：2020-04-30
2020-04-30，The CDE issued a notice to solicit public opinion on the 《Clinical technical requirements for unlisted drugs in China 》。

2020年4月30日，国家药品监督管理局药品审评中心发布对《境外已上市境内未上市药品临床技术要求》（征求意见稿），开始向社会各界公开征求意见，意见反馈截止2020年5月30日17：00前，要求通过电子邮箱反馈。

网址链接：http://www.cde.org.cn/news.do?method=viewInfoCommon&id=315054


Previous： The CDE issued a notice to solicit public opinion on the 《Initiation principles and procedures management rules of drug registration inspection (trail)》(Draft for public review)
Next： The CDE issued a notice to solicit public opinion on the 《Procedure for Review and Approval of Drug Listing Application Subject to Conditions (Draft for public review)》